ELTEX MED PP Homopolymer 100-MG03 is a nucleated, high-isotacticity polypropylene grade specifically engineered for single-use and reusable medical devices, drug delivery components, and diagnostic consumables. The designation “100” denotes a nominal melt mass-flow rate (MFR) of 10.0 g/10 min when measured according to ISO 1133-1:2022 at 230 °C under a 2.16 kg load, placing the material in a processing window optimized for thin-wall injection molding of syringe barrels, specimen containers, and pipette tips. “MG03” identifies the additive package, which incorporates a non-phthalate, non‑phenolic clarifier/nucleant combination and a tailored hindered‑amine light stabilizer (HALS) system that does not rely on migratory benzotriazole UV absorbers.
What Distinguishes a “MED” Homopolymer from Standard Injection Molding Grades?
The primary differentiation lies in the upstream polymerisation controls and the post-reactor additive selection protocol. Unlike general-purpose homopolymers such as ELTEX P HV001PF, MED PP Homopolymer 100-MG03 is manufactured under a dedicated campaign management system that prohibits the use of zinc stearate and calcium stearate as acid scavengers; instead, a synthetic hydrotalcite (Mg₆Al₂(CO₃)(OH)₁₆·4H₂O) is employed to neutralize residual catalyst acidity. This substitution reduces the concentration of water-extractable metallic soaps below 0.05 wt%, a critical parameter when USP <661.1> and Ph. Eur. 3.1.3 compliance is mandated. The catalyst system itself utilizes a fourth-generation Ziegler‑Natta donor (phthalate‑free) with a median particle size of 12 µm to minimize fines that otherwise contribute to increased volatile organic condensables during injection molding at elevated melt temperatures (240–260 °C). Furthermore, every production lot is subjected to a panel of biological reactivity tests per ISO 10993-5:2009 (cytotoxicity) and ISO 10993-10:2021 (irritation and skin sensitization), with acceptance criteria set at non‑cytotoxic (viability > 70 %) and negligible irritation scores (< 0.4).
Mechanical and Rheological Property Matrix Under ISO 527 and ISO 1133
Data are generated on injection‑molded Type 1A multipurpose specimens conditioned at 23 ± 2 °C and 50 ± 10 % RH for 88 hours. The values below represent the central tendency from 30 production lots over a 12‑month period. Single‑point observations without batch‑to‑batch statistics are excluded.
Tensile modulus (Et) according to ISO 527‑2:2012, test speed 1 mm/min, lies at 1750 MPa with an inter‑lot coefficient of variation of 2.1 %. Yield stress (σy) at 50 mm/min reaches 36.5 MPa; elongation at yield remains 7.8 %. The Charpy notched impact strength (ISO 179‑1/1eA:2023) at 23 °C registers 2.8 kJ/m², dropping to 1.6 kJ/m² at 0 °C. This brittle‑to‑semi‑ductile transition window requires careful design of snap‑fit features with radii not below 0.5 mm. The Vicat softening temperature (A50, ISO 306:2022, 10 N) stabilizes at 155 °C, indicating a heat deflection resistance suitable for steam sterilization at 121 °C without gross deformation under zero‑stress conditions. MFR consistency is verified at three set‑points: 2.16 kg (10.0 g/10 min), 5.0 kg (28.2 g/10 min), and 10.0 kg (64.5 g/10 min), enabling accurate calculation of a shear sensitivity exponent of 0.48 for Moldflow® simulation databases.
When Gamma Irradiation at 25–50 kGy Induces Chain Scission in Nucleated Systems
Medical device sterilization by cobalt‑60 gamma radiation presents a molecular weight‑degradation risk in all polypropylenes due to the predominant free‑radical chain scission mechanism initiated by abstraction of tertiary hydrogen atoms. In ELTEX MED PP Homopolymer 100-MG03, the nucleating system crystallizes the matrix into a fine spherulitic morphology with average spherulite diameters of 8–12 µm. This high‑surface‑area semicrystalline network increases the propensity for radical trapping at crystal‑amorphous interfaces, but also creates a higher density of tie‑molecule entanglements compared to unnucleated grades. Post‑irradiation evaluation at 25 kGy shows a reduction in weight‑average molecular weight (Mw) from approximately 380 000 g/mol to 210 000 g/mol (GPC‑MALLS, 1,2,4‑trichlorobenzene at 160 °C), translating to a post‑sterilization MFR shift to 26 g/10 min. At 50 kGy, MFR can exceed 55 g/10 min, and a measurable increase in carbonyl index (FTIR peak at 1718 cm⁻¹ relative to 2840 cm⁻¹) of 0.15 absorbance units is observed. The material’s long‑term ambient stability after irradiation is supported by the HALS package, which suppresses post‑oxidative chain branching for up to 5 years shelf life in single‑peel barrier packaging when stored below 30 °C. Nonetheless, for applications requiring 50 kGy double‑dose sterilization, published data for this specific configuration is limited; empirical validation of post‑exposure impact resistance on actual molded components is mandatory. Molders must incorporate a post‑irradiation annealing step of 2 hours at 80 °C to reduce free‑radical concentration and restore some degree of secondary crystallization, partially counteracting the embrittlement.
The compound is processed on standard three‑zone reciprocating‑screw injection molding machines with a compression ratio between 2.2:1 and 2.8:1 and an L/D ratio of 20:1 or greater. A reverse‑tapered shut‑off nozzle is recommended to prevent stringing from the high‑flow melt. Barrel temperature profile from feed zone to nozzle: 200 °C, 220 °C, 240 °C, 245 °C; nozzle set point 250 °C. The melt temperature measured by an immersion probe should remain within 235–255 °C. Exceeding 270 °C for a residence time of > 5 minutes initiates detectable thermal degradation, evidenced by yellowing (YI increase > 2.0 per ASTM E313) and a drop in injection‑pressure peak of more than 8 % at constant transfer position. Mold temperature at 30–50 °C is adequate for thin‑wall parts; for parts with wall thickness above 2.5 mm, a mold temperature of 60 °C is employed to reduce post‑mold shrinkage anisotropy below 1.4 % in flow direction and 1.2 % transverse. Pre‑drying is not routinely necessary if sealed, moisture‑barrier packaging is maintained; however, if exposure to ambient air at RH > 60 % exceeds 30 minutes, a desiccant drying step of 2 hours at 80 °C is required to prevent surface splay and hydrolysis‑induced molecular weight reduction in the barrel. Clamp force requirement: 3–5 kN/cm² of projected area. Processing of 0.4 mm‑wall pipette tips on a 64‑cavity hot‑runner tool has been demonstrated with cycle times of 5.2 seconds and a cavity‑to‑cavity fill imbalance below 1.8 % on an Engel e‑motion 280 (2800 kN clamp).
Comparative Leachables and Regulatory Compliance vs. Random Copolymer Grades
When selecting polyolefins for parenteral drug packaging or ophthalmic dispensers, the comparison between a homopolymer such as 100-MG03 and a propylene‑ethylene random copolymer (e.g., ELTEX MED PP Random 200‑RG06, typical C2 content 3.0–3.8 wt%) turns on extraction profiles and barrier properties. The homopolymer exhibits superior oxygen barrier (OTR at 23 °C, 0 % RH, 100 µm film: 1700 cm³/(m²·d·bar) vs. 2100 cm³/(m²·d·bar) for the random copolymer) and lower total organic carbon (TOC) leachables in water for injection at 121 °C over 1 hour (< 0.8 mg/L vs. 1.3 mg/L). The random copolymer, however, offers superior impact resistance at sub‑ambient temperatures, making it preferable for connector housings that undergo drop testing at ‑20 °C. The table below summarises critical compliance and property differentiators.
| Parameter | ELTEX MED PP 100-MG03 | MED Random 200‑RG06 | General‑Purpose Homopolymer |
|---|---|---|---|
| USP Class VI (USP <88>) | Passed, systemic injection & intracutaneous | Passed, systemic injection & intracutaneous | Not tested |
| ISO 10993‑4:2017 hemolysis (%) | 0.12 | 0.09 | Not applicable |
| Extractable metals (ICP‑MS, µg/g after 24 h at 50 °C in 3% acetic acid) | Al: <0.5, Ca: 1.2, Zn: <0.3 | Al: <0.5, Ca: 1.5, Zn: <0.3 | Zn: 12–25 (due to stearate) |
| Flexural modulus (ISO 178:2019) | 1650 MPa | 1100 MPa | 1500 MPa |
| Notched Charpy at ‑20 °C (kJ/m²) | 1.3 | 4.2 | 1.5 |
| Ethylene oxide residual (ppm) after aeration per ISO 10993‑7:2008 | <1 post 24 h purge at 40 °C | <1 post 24 h purge at 40 °C | Not controlled |
ELTEX MED PP Homopolymer 100-MG03 is also supplied under a Drug Master File (Type III) maintained with the U.S. FDA, and a change‑notification agreement is in place that guarantees 12‑month advance notice of any modification to catalyst, antioxidant, or process aid composition. This stability is not offered with standard polypropylene commodities, where formulation adjustments can occur within a single quarter without end‑user notification, potentially disrupting medical device regulatory submissions.
A further processing distinction emerges in multi‑material assemblies. When 100-MG03 is overmolded onto a thermoplastic elastomer (TPE) with a styrene‑ethylene‑butylene‑styrene (SEBS) backbone, the absence of migratory slip agents and low molecular weight oligomers (< 500 ppm hexane extractables per FDA 21 CFR 177.1520) results in peel strengths that can exceed 45 N/25 mm without the need for plasma or corona pretreatment. However, the homopolymer’s poor wetting characteristics against silicone‑based adhesives necessitate a surface activation step of oxygen plasma (200 W, 60 seconds) to raise surface energy from 29 mN/m to > 52 mN/m, measured by contact angle with diiodomethane per ISO 19403‑2:2020.
Avoid combination with copper‑based pigments or copper‑phthalocyanine masterbatches at concentrations exceeding 0.5 wt% when the part is intended for gamma irradiation, as copper ions catalyze the radiolytic oxidation manifold, increasing the rate of chain scission beyond the design bounds of the HALS package. Similarly, amine‑based adhesion promoters (e.g., amino‑silanes) must not be incorporated into pre‑compounded feeds, because they form adducts with residual peroxides from the controlled‑rheology visbreaking stage, causing premature crosslinking and gel formation visible as fisheyes on molded surfaces. Published data for amine‑grafted adhesion systems in direct melt contact with this polymer is absent; practitioners should segregate such materials to post‑molding surface treatment only.